RxDoctor Payments Data

Michael Nichols, MD

Family Medicine · Rochester Hills, MINPI 1326020777

Payments from drug & device makers

$3,683in general payments, 2019–2025

Across 223 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$855
  • Novo Nordisk$624
  • AstraZeneca$368
  • Lilly USA, LLC$244
  • AbbVie$210
  • Amgen$201
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,676100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,683 in reported general payments places this provider in the 85th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$93,423
Medicare patients
276
Services billed
2,783

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban49$56,165
JardianceEmpagliflozin40$50,619
EliquisApixaban31$48,237
MounjaroTirzepatide37$47,919
OzempicSemaglutide39$42,497
RybelsusSemaglutide12$24,311
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$23,916
FarxigaDapagliflozin Propanediol11$16,751
Breo ElliptaFluticasone/Vilanterol21$13,711
AbrysvoRsv Vacc, Pref A And Pref B/Pf30$9,542
ShingrixVaricella-Zoster Ge/As01b/Pf39$8,649
Atorvastatin Calcium542$6,437
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$5,030
Novolog FlexpenInsulin Aspart15$4,427
Metoprolol Succinate197$4,350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$624$66,80751 claims
PfizerEliquis, Abrysvo$855$57,77961 claims
Boehringer IngelheimJardiance$151$50,61940 claims
Lilly USA, LLCMounjaro$244$47,91937 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$189$46,27578 claims
AstraZenecaFarxiga$368$16,75111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →